TY - JOUR
T1 - Impact of a Perioperative Smoking and Alcohol Cessation Intervention on Health-related Quality of Life in Patients Undergoing Radical Cystectomy
T2 - A Randomised Controlled Trial
AU - Lauridsen, Susanne Vahr
AU - Tønnesen, Hanne
AU - Thind, Peter
AU - Rasmussen, Mette
AU - Kallemose, Thomas
AU - Thomsen, Thordis
N1 - Copyright © 2025 The Author(s). Published by Elsevier B.V. All rights reserved.
PY - 2025/11
Y1 - 2025/11
N2 - BACKGROUND AND OBJECTIVE: The impact of a smoking and alcohol cessation intervention on health-related quality of life (HRQoL) following radical cystectomy (RC) is unclear. This study aimed to evaluate the effect of a 6-wk perioperative smoking and/or alcohol cessation intervention on HRQoL. A secondary objective was to assess the difference in HRQoL between patients with more than two and those with fewer complications.METHODS: From 2014 to 2018, 104 patients referred to RC who smoked daily or consumed at least three alcohol units per day were enrolled in a multicentre randomised clinical trial. Participants were assigned to a 6-wk intensive smoking and/or alcohol cessation programme or standard care. The smoking cessation programme had five meetings in 6 wk and was based on the principles of motivational interviewing, balanced decision-making, and the transtheoretical model of change. HRQoL was assessed at baseline, and 6 and 12 mo using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 and BLM30 questionnaires. Linear regression models were used to analyse the association between intervention, complications, and HRQoL.KEY FINDINGS AND LIMITATIONS: There were differences in baseline demographic and lifestyle factors between groups. At the end of intervention, 51% of the intervention group and 27% of the control group quit successfully; after 12 mo, 21% and 36%, respectively, were quitters. No significant differences in HRQoL were found between the intervention and control groups. However, patients with more than two complications had significantly lower HRQoL on the QLQ-C30 scale, while no difference was observed on the BLM30 scale. A study limitation is the nonparticipation rate of 53%.CONCLUSIONS AND CLINICAL IMPLICATIONS: The cessation intervention did not impact HRQoL significantly in patients undergoing RC. However, patients with more than two complications experienced reduced HRQoL, highlighting the importance of identifying at-risk patients preoperatively.
AB - BACKGROUND AND OBJECTIVE: The impact of a smoking and alcohol cessation intervention on health-related quality of life (HRQoL) following radical cystectomy (RC) is unclear. This study aimed to evaluate the effect of a 6-wk perioperative smoking and/or alcohol cessation intervention on HRQoL. A secondary objective was to assess the difference in HRQoL between patients with more than two and those with fewer complications.METHODS: From 2014 to 2018, 104 patients referred to RC who smoked daily or consumed at least three alcohol units per day were enrolled in a multicentre randomised clinical trial. Participants were assigned to a 6-wk intensive smoking and/or alcohol cessation programme or standard care. The smoking cessation programme had five meetings in 6 wk and was based on the principles of motivational interviewing, balanced decision-making, and the transtheoretical model of change. HRQoL was assessed at baseline, and 6 and 12 mo using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 and BLM30 questionnaires. Linear regression models were used to analyse the association between intervention, complications, and HRQoL.KEY FINDINGS AND LIMITATIONS: There were differences in baseline demographic and lifestyle factors between groups. At the end of intervention, 51% of the intervention group and 27% of the control group quit successfully; after 12 mo, 21% and 36%, respectively, were quitters. No significant differences in HRQoL were found between the intervention and control groups. However, patients with more than two complications had significantly lower HRQoL on the QLQ-C30 scale, while no difference was observed on the BLM30 scale. A study limitation is the nonparticipation rate of 53%.CONCLUSIONS AND CLINICAL IMPLICATIONS: The cessation intervention did not impact HRQoL significantly in patients undergoing RC. However, patients with more than two complications experienced reduced HRQoL, highlighting the importance of identifying at-risk patients preoperatively.
KW - Alcohol cessation
KW - Bladder cancer
KW - Health-related quality of life
KW - Radical cystectomy
KW - Smoking cessation
KW - Postoperative Complications/prevention & control
KW - Humans
KW - Middle Aged
KW - Male
KW - Alcohol Drinking
KW - Urinary Bladder Neoplasms/surgery
KW - Cystectomy/methods
KW - Quality of Life
KW - Smoking Cessation/methods
KW - Female
KW - Surveys and Questionnaires
KW - Aged
KW - Motivational Interviewing
KW - Smoking
UR - http://www.scopus.com/inward/record.url?scp=105012122686&partnerID=8YFLogxK
U2 - 10.1016/j.euf.2025.07.009
DO - 10.1016/j.euf.2025.07.009
M3 - Journal article
C2 - 40744855
SN - 2405-4569
VL - 11
SP - 940
EP - 950
JO - European Urology Focus
JF - European Urology Focus
IS - 6
ER -